{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T08:29:25Z","timestamp":1773563365485,"version":"3.50.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2005,11]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) is a new free radical scavenger that is used for the treatment of adult acute cerebral infarction in Japan. We examined the effect of edaravone on the optimal duration of treatment, the long-term effect on the brain, and the effect on learning and memory disability in a rat model of neonatal hypoxic\u2013ischemic encephalopathy.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            Seven-day-old Wistar rats were subjected to left common carotid artery ligation then 2 hours of hypoxic\u2013ischemic insult or sham operation. Edaravone was administered intraperitoneally (9 mg\/kg) after hypoxic\u2013ischemic insult every 24 hours for 2, 5, or 10 consecutive days. The neuroprotective effect of edaravone was evaluated by behavioral test and histological analysis.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Two-day treatment with edaravone significantly gave protection to the learning and memory capability, as well as morphological recovery compared with control rats. Five-day treatment showed morphological improvement but no behavioral improvement. In contrast, 10-day treatment did not show either morphological or behavior improvement.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusions\u2014<\/jats:italic>\n            <\/jats:bold>\n            These findings indicate that edaravone is a promising candidate as a treatment of choice for neonatal hypoxic\u2013ischemic encephalopathy, when its use is limited to the acute phase after hypoxia\u2013ischemia.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000185653.49740.c6","type":"journal-article","created":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:44:27Z","timestamp":1128645867000},"page":"2468-2474","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Short-Term Administration of a New Free Radical Scavenger, Edaravone, Is More Effective Than its Long-Term Administration for the Treatment of Neonatal Hypoxic\u2013Ischemic Encephalopathy"],"prefix":"10.1161","volume":"36","author":[{"given":"Jesmin I.","family":"Noor","sequence":"first","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Aoo","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumie","family":"Ohta","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyomu","family":"Ikenoue","sequence":"additional","affiliation":[{"name":"From the Department of Obstetrics and Gynecology (J.I.N., T. Ikeda, T. Ikenoue), Faculty of Medicine, University of Miyazaki, Miyazaki, and the Department of Neuropharmacology (K.M., N.A., S.O., N.E., K.I., M.F.), Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1159\/000047088"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00573-6"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(97)00027-2"},{"key":"e_1_3_2_4_2","first-page":"206","volume":"66","year":"1994","unstructured":"Hagberg H, Gilland E, Diemer NH, Andine P. Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol Neonate. 1994; 66: 206\u2013213.","journal-title":"Biol Neonate"},{"key":"e_1_3_2_5_2","first-page":"405","volume":"33","year":"1993","unstructured":"Palmer C, Towfighi J, Roberts R, Heitjan DF. Allopurinol administered after inducing hypoxic-ischemia reduces brain injury in 7-day-old rats. Pediatr Res. 1993; 33: 405\u2013411.","journal-title":"Pediatr Res"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199507000-00001"},{"key":"e_1_3_2_7_2","first-page":"85","volume":"422","year":"1997","unstructured":"Hagberg H, Bona E, Gilland E, Puka-Sandvall M. Hypoxia-ischemia model in the 7-day-old rat: possibilities and shortcomings. Acta Paediatr Suppl. 1997; 422: 85\u201388.","journal-title":"Acta Paediatr Suppl"},{"key":"e_1_3_2_8_2","first-page":"1","volume":"36","year":"1960","unstructured":"Levine S. Anoxic-ischemic encephalopathy in rats. Am J Pathol. 1960; 36: 1\u201317.","journal-title":"Am J Pathol"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-4328(00)00287-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1992.263.2.C267"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1037\/0097-7403.2.2.97"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0023-9690(81)90020-5"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.24.2.8421825"},{"key":"e_1_3_2_14_2","unstructured":"Japan Pharmacists Education Center. Edaravone (Radicut infusion 30 mg). New Drug Approval Package No. 11. 2001; 398\u2013403."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00541-0"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760000301141"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.3.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2003.12.012"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00454.x"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.20.9.2505409"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-3278(88)90127-5"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.19.4.2834836"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.devbrainres.2004.04.006"},{"key":"e_1_3_2_24_2","unstructured":"Noor JI Ikeda T Ueda Y Ikenoue T. A free radical scavenger edaravone inhibits lipid peroxidation and the production of nitric oxide in hypoxic-ischemic brain damage of neonatal rats. Am J Obstet Gynecol. in press."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2004.09.003"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000059221.40073.82"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.32.9.2185"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000185653.49740.c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:52:26Z","timestamp":1715550746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000185653.49740.c6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["10.1161\/01.STR.0000185653.49740.c6"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000185653.49740.c6","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"2005-05-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-08-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-10-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}